コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rivation or disease-related abnormalities of n-3 polyunsaturated fatty acids.
2 l role in the bio-production of both n-6 and n-3 polyunsaturated fatty acids.
3 f syndecan 1 in prostate epithelial cells by n-3 polyunsaturated fatty acids.
4 e endogenous synthesis of these longer chain n-3 polyunsaturated fatty acids.
5 ng controversy over the dietary ratio of n-6/n-3 polyunsaturated fatty acids.
6 te (LFHCC) diet supplemented with long-chain n-3 polyunsaturated fatty acids (1.2 g/d); or an LFHCC d
7 andomized to placebo or supplementation with n-3 polyunsaturated fatty acids (2 g/day) (eicosapentaen
8 s which address three emerging mechanisms of n-3 polyunsaturated fatty acids action: (1) metabolic in
9 ents resulted in increases in plasma DHA and n-3 polyunsaturated fatty acids and in decreases in some
11 links between supplementation with fish oil (n-3 polyunsaturated fatty acids) and cardiovascular dise
12 he effects of trans fatty acids, oleic acid, n-3 polyunsaturated fatty acids, and conjugated linoleic
16 Maternal supplementation with long-chain n-3 polyunsaturated fatty acids can have immunologic eff
17 of polyunsaturated fatty acids, particularly n-3 polyunsaturated fatty acids, can modulate immune and
23 had an opposite association (P = 0.004), and n-3 polyunsaturated fatty acids did not show any associa
26 ytes loaded with Indo-1 to determine how the n-3 polyunsaturated fatty acid eicosapentaenoic acid (EP
27 olvins and protectins, which derive from the n-3 polyunsaturated fatty acids eicosapentaenoic acid (E
28 arine fatty acid intake [the sum of omega-3 (n-3) polyunsaturated fatty acids eicosapentanoic acid, d
31 Experimental data suggest that long-chain n-3 polyunsaturated fatty acids found in fish have antia
32 s, there is growing evidence that long-chain n-3 polyunsaturated fatty acids found in fish oil suppre
34 cal studies generally support high intake of n-3 polyunsaturated fatty acids from marine sources to p
35 presecretory proteolysis (PERPP) of ApoB by n-3 polyunsaturated fatty acids has been found to result
40 ololipidomics was used to identify SPMs from n-3 polyunsaturated fatty acids in human IBD colon biops
41 re differentially modulated by saturated and n-3 polyunsaturated fatty acids in macrophages and dendr
42 tical utility of the dietary ratio of n-6 to n-3 polyunsaturated fatty acids in optimizing the benefi
43 Trials have shown a beneficial effect of n-3 polyunsaturated fatty acids in patients with a previ
44 her supplementation with 2.7 g of long-chain n-3 polyunsaturated fatty acids in pregnancy can reduce
45 o outline recent findings on the efficacy of n-3 polyunsaturated fatty acids in the prevention/treatm
46 entation with docosahexaenoic acid (DHA), an n-3 polyunsaturated fatty acid, in the 3xTg-AD mouse mod
47 saturated fatty acids activate TLRs, whereas n-3 polyunsaturated fatty acids inhibit agonist-induced
49 ast, polyunsaturated fatty acids, especially n-3 polyunsaturated fatty acids, inhibited the activatio
52 immune responses by saturated fatty acid and n-3 polyunsaturated fatty acid is mediated at least in p
54 nanimous in concluding that the ratio of n-6/n-3 polyunsaturated fatty acids is of no value in modify
55 ions of the fish oil (FO)-derived long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFAs) eicosapen
60 yunsaturated fatty acid levels, and measured n-3 polyunsaturated fatty acid levels were positively as
62 ndividuals who consume diets low in omega-3 (n-3) polyunsaturated fatty acids may cognitively benefit
63 priate and timely to determine precisely how n-3 polyunsaturated fatty acids modulate cell signaling
64 ently, we have shown that dietary long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFA) largely pre
65 and animal model studies support a role for n-3 polyunsaturated fatty acids (n-3 PUFA) in prevention
68 Experimental studies suggest that long-chain n-3 polyunsaturated fatty acids (n-3 PUFAs) may reduce t
69 on of the leptin promoter and the effects of n-3 polyunsaturated fatty acids (n-3 PUFAs), which is cl
70 is that lowering the dietary ratio of n-6 to n-3 polyunsaturated fatty acids (n-6:n-3) would modify t
71 nately, the molecular basis of the effect of n-3 polyunsaturated fatty acids on inflammation/colitis-
72 this study was to investigate the effects of n-3 polyunsaturated fatty acids on the prevalence of nos
73 The question of whether the ratio of n-6/n-3 polyunsaturated fatty acids or total amounts of diet
74 lerated, and low-cost regimen, consisting of n-3 polyunsaturated fatty acids plus vitamins C and E su
75 ulating and hepatic fatty acids in mice, and n-3 polyunsaturated fatty acids prevented palmitate inhi
77 hown that the antiarrhythmic effects of free n - 3 polyunsaturated fatty acids (PUFA) are associated
78 lable evidence for cardiovascular effects of n-3 polyunsaturated fatty acid (PUFA) consumption, focus
79 lic fate of the intermediary long-chain (LC) n-3 polyunsaturated fatty acid (PUFA) docosapentaenoic a
80 This study determined the effectiveness of n-3 polyunsaturated fatty acid (PUFA) ingestion in ameli
81 eafood, have suggested that increased marine n-3 polyunsaturated fatty acid (PUFA) intake during preg
82 Findings regarding the association between n-3 polyunsaturated fatty acid (PUFA) status and depress
84 he molecular properties of immunosuppressive n-3 polyunsaturated fatty acids (PUFA) have not been ful
87 imal molecular targets through which dietary n-3 polyunsaturated fatty acids (PUFA) suppress the infl
88 investigated the in vivo ability of dietary n-3 polyunsaturated fatty acids (PUFA) to alter caveolae
89 uggest that increased intake of the omega-3 (n-3) polyunsaturated fatty acid (PUFA) docosahexaenoic a
92 entaenoic acid and 2.2 g docohexaenoic acid (n-3 polyunsaturated fatty acid [PUFA] diet; n = 5) or pl
93 d profile are being developed to improve n-6/n-3 polyunsaturated fatty acid (PUFAs) ratio in edible o
94 tors for the cardioprotective effects of the n-3 polyunsaturated fatty acids (PUFAs) against lethal a
95 n inverse relation between dietary intake of n-3 polyunsaturated fatty acids (PUFAs) and age-related
97 the association between intake of long-chain n-3 polyunsaturated fatty acids (PUFAs) and risk of atri
98 omponent of the nervous system, and maternal n-3 polyunsaturated fatty acids (PUFAs) are an important
101 During cardiac ischaemia antiarrhythmic n-3 polyunsaturated fatty acids (PUFAs) are released fol
105 Whether the dietary intake of long-chain n-3 polyunsaturated fatty acids (PUFAs) from seafood red
112 The effect of marine- and plant-derived n-3 polyunsaturated fatty acids (PUFAs) on T cell-mediat
113 mpact of the common APOE genotype and marine n-3 polyunsaturated fatty acids (PUFAs) on the developme
114 mal feeding studies, and probably in humans, n-3 polyunsaturated fatty acids (PUFAs) prevent fatal is
116 els, and lower dietary intakes of long-chain n-3 polyunsaturated fatty acids (PUFAs) than do age- and
117 different types of fish meals and long-chain n-3 polyunsaturated fatty acids (PUFAs) to measures of a
119 At sufficiently high intakes, long-chain n-3 polyunsaturated fatty acids (PUFAs), as found in oil
122 dence of the preventive benefits of omega-3 (n-3) polyunsaturated fatty acids (PUFAs) in breast cance
123 igher intake of fish and long-chain omega-3 (n-3) polyunsaturated fatty acids (PUFAs) may be associat
125 all trials have evaluated whether long-chain n-3-polyunsaturated fatty acids (PUFAs) reduce postopera
126 These results suggest that fish oil (mainly n-3 polyunsaturated fatty acids [PUFAs]) can synergize w
128 The results show that administration of n-3 polyunsaturated fatty acids reduces the risk of noso
130 (rich in saturated, monounsaturated, n-6, or n-3 polyunsaturated fatty acids, respectively) by hepato
131 cts of the nonenzymatic oxidation of n-6 and n-3 polyunsaturated fatty acids, respectively, were meas
135 were increased markedly, whereas all n-6 and n-3 polyunsaturated fatty acids were nearly depleted in
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。